SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Human & Experimental Toxicology
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Lailey, A. F
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lailey, A. F
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Oral N-acetylcysteine protects against perfluoroisobutene toxicity in rats

Alison F Lailey

Medical Countermeasures, Chemical and Biological Defence, Defence Evaluation and Research Agency (DERA), Porton Down, Salisbury, Wilts, SP4 0JQ, UK

1 Perfluoroisobutene, a pyrolysis product of polytetra fluoroethene may cause pulmonary oedema and death when inhaled. Oral N-acetylcysteine has shown protection against inhalation of perfluoroisobutene and in this study we have tried to elucidate the mechanism by which protection is mediated.

2 Protection against the lethal effects of inhaled per fluoroisobutene has been shown when N-acetylcys teine has been orally administered 4, 6 or 8 h before gas exposure.

3 Plasma levels of cysteine, glutathione and N-acetylcys teine were increased for up to 7 h following oral administration of Nac.

4 N-acetylcysteine was not detected in the bronchio alveolar lavage fluid following oral administration.

5 Duration of protection in vivo has been related to the duration of increased thiol levels in the plasma.

Key Words: perfluoroisobutene • N-acetylcysteine • cysteine • glu tathione • protection

Human & Experimental Toxicology, Vol. 16, No. 4, 212-216 (1997)
DOI: 10.1177/096032719701600410


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
International Journal of ToxicologyHome page
D. P. Arfsten, E. W. Johnson, A. R. Thitoff, A. E. Jung, E. R. Wilfong, S. M. Lohrke, T. A. Bausman, J. S. Eggers, and A. J. Bobb
Impact of 30-Day Oral Dosing with N-acetyl-L-cysteine on Sprague-Dawley Rat Physiology
International Journal of Toxicology, July 1, 2004; 23(4): 239 - 247.
[Abstract] [Full Text] [PDF]


Home page
Hum Exp ToxicolHome page
S Attri, S V Rana, K Vaiphei, C P Sodhi, R Katyal, R C Goel, C K Nain, and K Singh
Isoniazid - and rifampicin-induced oxidative hepatic injury - protection by N-acetylcysteine
Human and Experimental Toxicology, September 1, 2000; 19(9): 517 - 522.
[Abstract] [PDF]



Advertisement